These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 5006609

  • 1. [Personal experience with Muthesa].
    Hradský M.
    Cesk Gastroenterol Vyz; 1967 Sep; 21(6):409-11. PubMed ID: 5006609
    [No Abstract] [Full Text] [Related]

  • 2. [Drug therapy of ulcer prior to diagnostic endoscopy].
    Havelund T, Schaffalitzky de Muckadell OB.
    Ugeskr Laeger; 1988 Jan 11; 150(2):88-90. PubMed ID: 3376281
    [No Abstract] [Full Text] [Related]

  • 3. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN.
    East Afr Med J; 2005 Dec 11; 82(12):601-2. PubMed ID: 16619702
    [No Abstract] [Full Text] [Related]

  • 4. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ, Lee DH, Kim N, Jung SH, Kim JW, Hwang JH, Park YS, Lee KH, Jung HC, Song IS.
    Hepatogastroenterology; 2007 Jun 11; 54(76):1293-6. PubMed ID: 17629092
    [Abstract] [Full Text] [Related]

  • 5. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U, Raps S, Plein K, Leodolter A, Hotz Dagger J, Malfertheiner P.
    Dtsch Med Wochenschr; 2004 Mar 26; 129(13):671-5. PubMed ID: 15026962
    [Abstract] [Full Text] [Related]

  • 6. Management of outpatients with dyspepsia.
    Millard P, Fitzpatrick BP.
    J Fam Pract; 1997 Sep 26; 45(3):199-200. PubMed ID: 9312557
    [No Abstract] [Full Text] [Related]

  • 7. Helicobacter pylori infection.
    Delaney B, Moayyedi P, Forman D.
    Clin Evid; 2002 Jun 26; (7):414-28. PubMed ID: 12230667
    [No Abstract] [Full Text] [Related]

  • 8. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ, Liu CF, Crump C, Brousal A.
    Am J Gastroenterol; 2003 Sep 26; 98(9):1952-62. PubMed ID: 14499771
    [Abstract] [Full Text] [Related]

  • 9. Management of dyspepsia and peptic ulcer disease.
    Ryan SW.
    Altern Ther Health Med; 2005 Sep 26; 11(5):26-9; quiz 30. PubMed ID: 16189945
    [Abstract] [Full Text] [Related]

  • 10. [A new drug, the hydrochloride of the beta-dimethylaminoethylic ester of alpha, alpha-diphenyl-alpha-propargoxyacetic acid in therapy of gastroduodenal disorders].
    Barlattani M, Carignola W.
    Clin Ter; 1970 Feb 28; 52(4):343-60. PubMed ID: 5527879
    [No Abstract] [Full Text] [Related]

  • 11. Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients.
    Deltenre M, Jonas C, van Gossum M, Buset M, Otero J, De Koster E.
    Eur J Gastroenterol Hepatol; 1995 Aug 28; 7 Suppl 1():S39-44. PubMed ID: 8574734
    [Abstract] [Full Text] [Related]

  • 12. Pharmacotherapy of acid-peptic disorders.
    Burkard PG.
    Lippincotts Prim Care Pract; 1998 Aug 28; 2(4):398-409. PubMed ID: 9709085
    [Abstract] [Full Text] [Related]

  • 13. [Ulcer-healing effect of alanton].
    Luchkova MM.
    Ter Arkh; 1978 Aug 28; 50(1):37-8. PubMed ID: 635794
    [No Abstract] [Full Text] [Related]

  • 14. H2-receptor antagonists.
    Nurs Times; 1978 Aug 28; 100(44):33. PubMed ID: 15552489
    [No Abstract] [Full Text] [Related]

  • 15. Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study.
    Zullo A, Rinaldi V, Pugliano F, Diana F, Attili AF.
    Am J Gastroenterol; 1997 Nov 28; 92(11):2029-31. PubMed ID: 9362185
    [Abstract] [Full Text] [Related]

  • 16. [Tolerance and safety of anti-Helicobacter drugs in the treatment of ulcer disease].
    Artamonov VE, Masharova AA, Gorodetskiĭ VV, Vertkin AL.
    Klin Med (Mosk); 2001 Nov 28; 79(2):53-7. PubMed ID: 11419089
    [Abstract] [Full Text] [Related]

  • 17. The development of clinical practice guidelines for treatment of peptic acid diseases in a VA ambulatory care clinic--a comment.
    Holt RJ, Fort J.
    Pharmacotherapy; 1996 Nov 28; 16(3):480-1; discussion 482-3. PubMed ID: 8726612
    [No Abstract] [Full Text] [Related]

  • 18. Chronic acid-related disorders are common and underinvestigated.
    Majumdar SR, Soumerai SB, Farraye FA, Lee M, Kemp JA, Henning JM, Schrammel P, LeCates RF, Ross-Degnan D.
    Am J Gastroenterol; 2003 Nov 28; 98(11):2409-14. PubMed ID: 14638341
    [Abstract] [Full Text] [Related]

  • 19. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K, Nowak A, Marlicz K, Depczyńska A, Dzieniszewski J, Milewski B, Gabryelewicz A, Kosidło S.
    Pol Tyg Lek; 1984 Nov 19; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical trial of Alcid V in peptic ulcer therapy].
    Vŭrbanov G, Rusinov E, Danev I, Glinkova V, Panecheva K.
    Vutr Boles; 1981 Nov 19; 20(5):27-34. PubMed ID: 7034375
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.